Requirement of NK cells for selective A2A receptor blockade to suppress CD73+ tumor metastasis

Immunotherapy

Volumn 6, Issue 1, 2014, Pages 19-21

  Qin, Lei ^a   Thompson, Linda F ^b   Kuzel, Timothy M ^a   Zhang, Bin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

adenosine receptor; CD73; ecto 5 nucleotidase; metastasis; NK cell

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; COMPLEMENTARY DNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HOST; HUMAN; IMMUNOCOMPETENT CELL; LUNG METASTASIS; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

5'-NUCLEOTIDASE; ANIMALS; HUMANS; KILLER CELLS, NATURAL; NEOPLASMS, EXPERIMENTAL; RECEPTOR, ADENOSINE A2A;

EID: 84896523581     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.154     Document Type: Article

References (20)

1. Beavis PA, Stagg J, Darcy PK, Smyth MJ. CD73: a potent suppressor of antitumor immune responses. Trends. Immunol. 33, 231-237 (2012).
2. Zhang B. Opportunities and challenges for anti-CD73 cancer therapy. Immunotherapy 4, 861-865 (2012).
3. Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol. Rev. 161, 95-109 (1998).
4. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5́-nucleotidase (CD73). Purinergic Signal. 2, 351-360 (2006).
5. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7, 759-770 (2008).
6. Ohta A, Gorelik E, Prasad SJ et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl Acad. Sci. USA 103, 13132-13137 (2006).
7. Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J. Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J. Immunol. 188, 198-205 (2012).
8. Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29, 5346-5358 (2010).
9. Zhang B. CD73: a novel target for cancer immunotherapy. Cancer Res. 70, 6407-6411 (2010).
10. Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 32, 1743-1751 (2013).
11. Longhi MS, Robson SC, Bernstein SH, Serra S, Deaglio S. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J. Mol. Med. (Berl.) 91, 165-172 (2013).
12. Stagg J, Beavis PA, Divisekera U et al. CD73- deficient mice are resistant to carcinogenesis. Cancer Res. 72, 2190-2196 (2012).
13. Stagg J, Divisekera U, Duret H et al. CD73- deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res. 71, 2892-2900 (2011).
14. Stagg J, Divisekera U, McLaughlin N et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl Acad. Sci. USA 107, 1547-1552 (2010).
15. Jin D, Fan J, Wang L et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res. 70, 2245-2255 (2010).
16. Wang L, Fan, J, Thompson LF et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J. Clin. Invest. 121, 2371-2382 (2011).
17. Desmet CJ, Gallenne T, Prieur A et al. Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proc. Natl Acad. Sci. USA 110, 5139-5144 (2013).
18. Terp MG, Olesen KA, Arnspang EC et al. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells. J. Immunol. 191(8), 4165-4173 (2013).
19. Ryzhov S, Novitskiy SV, Goldstein AE et al. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J. Immunol. 187, 6120-6129 (2011).
20. Novitskiy SV, Ryzhov S, Zaynagetdinov R et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112, 1822-1831 (2008).